RVL Pharmaceuticals PLC (NASDAQ:RVLP)
| 0.0881 Delayed Data As of Sep 25 |  -0.0119 / -11.90%Today’s Change | 0.09 Today|||52-Week Range 2.42 | -92.13% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Assets | Cash | 19.6M | 34.7M | 70.8M | -- | |
| Short Term Investment Cash | -78.1M | 15.2M | 36.1M | -- | ||
| Cash & Short Term Investments | 19.6M | 34.7M | 70.8M | -- | ||
| Receivables | Receivables | 45.3M | 37.6M | 56.4M | -- | |
| Inventories | Inventories | 19.8M | 16.9M | 24.4M | -- | |
| Current Assets | Other Current Assets | 9.5M | 25.8M | 20.7M | -- | |
| Current Assets | 94.2M | 115.1M | 172.4M | -- | ||
| Total Assets | Property, Plant and Equipment - Gross | 30.1M | 37.3M | 41.5M | -- | |
| Depreciation | -2.3M | -5.9M | -10.2M | -- | ||
| Intangible Assets | 854.1M | 738.2M | 591.2M | -- | ||
| Other Assets | 856.6M | 739.1M | 592.0M | -- | ||
| Total Assets | 978.5M | 885.7M | 795.6M | -- | ||
| Liabilities | Accounts Payable | 35.0M | 36.1M | 24.9M | -- | |
| Short Term Debt | 5.3M | 6.7M | 1.9M | -- | ||
| Accrued Expenses | 28.0M | 32.1M | 78.5M | -- | ||
| Other Current Liabilities | 71.6M | 75.6M | 78.6M | -- | ||
| Other Liabilities | 117.8M | 124.7M | 114.4M | -- | ||
| Total Liabilities | Long Term Debt | 323.7M | 314.0M | 266.9M | -- | |
| Deferred Taxes | -67.6M | -25.4M | -26.2M | -- | ||
| Other Liabilities | 4.2M | 2.4M | 1.8M | -- | ||
| Total Liabilities | 513.3M | 466.4M | 409.4M | -- | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | -- | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | -- | -- | |
| Common Equity | 465.2M | 419.3M | 386.3M | -- | ||
| Total Shareholder Equity | 465.2M | 419.3M | 386.3M | -- | ||
| Share Information | Common Shares Outstanding | 52.5M | 52.5M | 52.5M | -- | |
| Addtl. Info. | No data currently available for this section. | |||||
